{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1431946", "DateCompleted": {"Year": "1992", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "55", "Issue": "9", "PubDate": {"Year": "1992", "Month": "Sep"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Displacement activity of bisbenzylisoquinoline alkaloids at striatal 3H-SCH 23390 and 3H-raclopride binding sites.", "Pagination": {"StartPage": "1281", "EndPage": "1286", "MedlinePgn": "1281-6"}, "Abstract": {"AbstractText": ["Fifteen bisbenzylisoquinoline alkaloids (BBIQ) with one ether bridge (thaligrisine [1], berbamunine [2], dimethylgrisabine [3], pampulhamine [4], and methyl-dauricine [5]), with two ether bridges (homoaromoline, isotetrandrine, and obaberine), with one ether bridge and one biphenyl bridge (oxandrine, dimethylpseudoxandrine, pseudoxandrine, and antioquine) or secoderivatives (secoobaberine, secoantioquine, and secolucidine), were tested for their ability to displace 3H-raclopride or 3H-SCH 23390 from their specific dopaminergic binding sites to rat striatal membranes. The most active compounds were found in the group of BBIQs with one ether bridge. Inactive or weakly active compounds were found in this group of BBIQs with one ether bridge and in the other groups. Analysis of tridimensional representations indicates that the differnt activities among the BBIQs with one ether bridge could be related to strong differences between the spatial occupancy of these compounds according to their stereochemistry."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoires de Pharmacognosie et de Physiologie (Groupe VACOMED), Facult\u00e9 de M\u00e9decine et Pharmacie de Rouen, Saint Etienne Rouvray, France."}], "LastName": "Cortes", "ForeName": "D", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Figadere", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Saez", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Protais", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzazepines"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Dopamine D1"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Dopamine D2"}, {"RegistryNumber": "0", "NameOfSubstance": "Salicylamides"}, {"RegistryNumber": "430K3SOZ7G", "NameOfSubstance": "Raclopride"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzazepines"}, {"QualifierName": ["drug effects"], "DescriptorName": "Binding, Competitive"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Corpus Striatum"}, {"QualifierName": [], "DescriptorName": "France"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Isoquinolines"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Raclopride"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Dopamine D1"}, {"QualifierName": ["drug effects"], "DescriptorName": "Receptors, Dopamine D2"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Salicylamides"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "9", "Day": "1"}, {"Year": "1992", "Month": "9", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "9", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1431946", "10.1021/np50087a016"]}}]}